Carboplatin and paclitaxel plus avelumab compared with carboplatin and paclitaxel in advanced or recurrent endometrial cancer (MITO END-3): a multicentre, open-label, randomised, controlled, phase 2 trial
Titel:
Carboplatin and paclitaxel plus avelumab compared with carboplatin and paclitaxel in advanced or recurrent endometrial cancer (MITO END-3): a multicentre, open-label, randomised, controlled, phase 2 trial
Auteur:
Pignata, Sandro Scambia, Giovanni Schettino, Clorinda Arenare, Laura Pisano, Carmela Lombardi, Davide De Giorgi, Ugo Andreetta, Claudia Cinieri, Saverio De Angelis, Carmine Priolo, Domenico Casanova, Claudia Rosati, Marta Greco, Filippo Zafarana, Elena Schiavetto, Ilaria Mammoliti, Serafina Cecere, Sabrina Chiara Salutari, Vanda Scalone, Simona Farolfi, Alberto Di Napoli, Marilena Lorusso, Domenica Gargiulo, Piera Califano, Daniela Russo, Daniela Spina, Anna De Cecio, Rossella Chiodini, Paolo Perrone, Francesco